Youngsook Choi

592 total citations
16 papers, 279 citations indexed

About

Youngsook Choi is a scholar working on Genetics, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Youngsook Choi has authored 16 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Hematology. Recurrent topics in Youngsook Choi's work include Acute Myeloid Leukemia Research (5 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Youngsook Choi is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Youngsook Choi collaborates with scholars based in United States, Germany and Italy. Youngsook Choi's co-authors include Eugene Braunwald, Michele Mercuri, Robert P. Giugliano, Elliott M. Antman, Christian T. Ruff, Sabina A. Murphy, José Luis Zamorano, Jan Steffel, Philip E. Aylward and Harvey D. White and has published in prestigious journals such as Circulation, Blood and Gastroenterology.

In The Last Decade

Youngsook Choi

15 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youngsook Choi United States 7 195 91 46 25 23 16 279
Vincent ten Cate Germany 10 102 0.5× 96 1.1× 20 0.4× 11 0.4× 32 1.4× 35 249
Gheorghe‐Andrei Dan Romania 14 438 2.2× 46 0.5× 55 1.2× 16 0.6× 55 2.4× 71 536
Sven Pannach Germany 9 509 2.6× 362 4.0× 41 0.9× 10 0.4× 82 3.6× 11 608
Kagari Murasaki Japan 10 217 1.1× 80 0.9× 66 1.4× 4 0.2× 54 2.3× 19 296
Jeff Taylor United States 5 239 1.2× 178 2.0× 33 0.7× 55 2.2× 39 1.7× 5 325
Sara Biere‐Rafi Netherlands 7 112 0.6× 118 1.3× 17 0.4× 8 0.3× 79 3.4× 12 323
Jeong‐Eun Yi South Korea 8 207 1.1× 8 0.1× 39 0.8× 12 0.5× 39 1.7× 28 289
James Dickinson United Kingdom 10 123 0.6× 93 1.0× 45 1.0× 33 1.3× 122 5.3× 14 341
Matteo Santagostino Italy 6 183 0.9× 56 0.6× 23 0.5× 13 0.5× 74 3.2× 22 285
Bayram Ali Uysal Türkiye 11 166 0.9× 101 1.1× 21 0.5× 9 0.4× 49 2.1× 20 311

Countries citing papers authored by Youngsook Choi

Since Specialization
Citations

This map shows the geographic impact of Youngsook Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youngsook Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youngsook Choi more than expected).

Fields of papers citing papers by Youngsook Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youngsook Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youngsook Choi. The network helps show where Youngsook Choi may publish in the future.

Co-authorship network of co-authors of Youngsook Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Youngsook Choi. A scholar is included among the top collaborators of Youngsook Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youngsook Choi. Youngsook Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Salas, Maribel, et al.. (2022). Turalio Risk Evaluation and Mitigation Strategy for Treatment of Tenosynovial Giant Cell Tumor: Framework And Experience. Future Oncology. 18(13). 1595–1607. 11 indexed citations
3.
Kang, Dongwoo, Elizabeth Ludwig, Hannah Huang, et al.. (2021). Concentration–QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia. Cancer Chemotherapy and Pharmacology. 87(4). 513–523. 9 indexed citations
4.
Salas, Maribel, et al.. (2021). Evaluation of patient/caregiver and healthcare provider knowledge, attitudes and behavior for safety and use of pexidartinib. Journal of Comparative Effectiveness Research. 10(12). 953–967. 4 indexed citations
5.
Kang, Dongwoo, Elizabeth Ludwig, Hannah Huang, et al.. (2020). Population Pharmacokinetic Analysis of Quizartinib in Healthy Volunteers and Patients With Relapsed/Refractory Acute Myeloid Leukemia. The Journal of Clinical Pharmacology. 60(12). 1629–1641. 3 indexed citations
6.
Lewis, James H., Hans Gelderblom, Michiel A. J. van de Sande, et al.. (2020). Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors. The Oncologist. 26(5). e863–e873. 36 indexed citations
7.
Cortes, Jörge E., Siddhartha Ganguly, Alwin Krämer, et al.. (2019). Pooled Safety Analysis of Quizartinib Monotherapy in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML). Blood. 134(Supplement_1). 1372–1372. 2 indexed citations
8.
Qamar, Arman, Elliott M. Antman, Christian T. Ruff, et al.. (2019). Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease. Journal of the American College of Cardiology. 74(2). 179–189. 32 indexed citations
9.
10.
Aisenberg, James, Jeffrey I. Weitz, Christian T. Ruff, et al.. (2018). Gastrointestinal Bleeding With Edoxaban Versus Warfarin. Circulation Cardiovascular Quality and Outcomes. 11(5). e003998–e003998. 38 indexed citations
11.
Brekelmans, Marjolein, Rupert Bauersachs, Z Boda, et al.. (2016). Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists. Thrombosis and Haemostasis. 116(7). 155–161. 15 indexed citations
12.
Steffel, Jan, Robert P. Giugliano, Eugene Braunwald, et al.. (2016). Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling. Journal of the American College of Cardiology. 68(11). 1169–1178. 116 indexed citations
13.
Aisenberg, James, Jay Desai, Jeffrey I. Weitz, et al.. (2016). 792 Do Concurrent Gastroprotective Agents Impact Gastrointestinal Bleeding Rates in Edoxaban Users? Results From the ENGAGE-AF TIMI 48 Trial. Gastroenterology. 150(4). S165–S165. 1 indexed citations
14.
Steffel, Jan, Robert P. Giugliano, Eugene Braunwald, et al.. (2015). Abstract 11748: Edoxaban versus Warfarin in Patients at Increased Risk of Falling - A Subgroup Analysis of the ENGAGE AF-TIMI 48 Trial. Circulation. 132(suppl_3). 4 indexed citations
15.
Aisenberg, James, Jay Desai, Jeffrey I. Weitz, et al.. (2015). Abstract 17392: Gastrointestinal Bleeding With Edoxaban versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial. Circulation. 132(suppl_3). 5 indexed citations
16.
Choi, Youngsook, et al.. (1997). The Health Promoting Program of the Elderly Who use Senior Citizens' Center. Journal of Korean Public Health Nursing. 11(1). 14–25. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincent ten Cate Breakdown of academic impact, for papers by Gheorghe‐Andrei Dan Breakdown of academic impact, for papers by Sven Pannach Breakdown of academic impact, for papers by Kagari Murasaki Breakdown of academic impact, for papers by Jeff Taylor Breakdown of academic impact, for papers by Sara Biere‐Rafi Breakdown of academic impact, for papers by Jeong‐Eun Yi Breakdown of academic impact, for papers by James Dickinson Breakdown of academic impact, for papers by Matteo Santagostino Breakdown of academic impact, for papers by Bayram Ali Uysal
Rankless by CCL
2026